Trial Profile
Pharmacodynamic evaluation of moxifloxacin in pleural space infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2015
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Empyema; Respiratory tract infections
- Focus Pharmacodynamics; Pharmacokinetics
- 08 Sep 2015 New trial record